Jennifer Swainson
Edmonton, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Are the current safety measures for the treatment of depression with esketamine sufficient?
Journal: Expert opinion on drug safety
Published: February 03, 2026
A scoping review: ketamine or esketamine when used to assist psychotherapy or in combination with psychotherapy for the management of depression in adults.
Journal: Npj mental health research
Published: January 04, 2026
Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.
Journal: Psychopharmacology
Published: December 12, 2025
Ketamine and esketamine for the prevention of postpartum depression: A systematic review and network meta-analysis, with an integrated evidence synthesis.
Journal: Psychiatry research
Published: November 21, 2025
Ketamine, Psychedelics, and Psychotherapy: Reframing, Redefining, Renaming Treatment Models.
Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie
Published: October 28, 2025
Interventional Psychiatry and Emerging Treatments for Posttraumatic Stress Disorder (PTSD): A Systematic Review.
Journal: Psychiatry and clinical psychopharmacology
Published: August 29, 2025
Evolving Psychotherapeutic Approaches for PTSD: Beyond the Fear-Based Model.
Journal: Psychiatry and clinical psychopharmacology
Published: August 28, 2025
Ketamine and Perinatal Mental Health: Problems and Potentials.
Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie
Published: April 13, 2025
Letter to the editor in response to: Blood pressure changes during ketamine infusion for the treatment of depression.
Journal: General hospital psychiatry
Published: February 28, 2025
A retrospective report of a ketamine-augmented, transdiagnostic psychiatric outpatient psychotherapy program.
Journal: Journal of military, veteran and family health
Published: February 06, 2025
Efficacy and Safety of Glucagon-Like Peptide-1 Agonists for Psychiatric Symptoms: A Systematic Review.
Journal: Brain and behavior
Published: January 14, 2025
Last Updated: 09/26/2026